Profile data is unavailable for this security.
About the company
Bactiguard Holding AB is a Sweden-based company engaged in the development of solutions for preventing of device-related healthcare associated infections (HAI). Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. It consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The Company is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.
- Revenue in SEK (TTM)230.51m
- Net income in SEK-76.04m
- Incorporated2010
- Employees177.00
- LocationBactiguard Holding ABBiblioteksgatan 25STOCKHOLM 114 35SwedenSWE
- Phone+46 84405880
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Optomed Oyj | 167.44m | -55.23m | 1.04bn | 110.00 | -- | 3.33 | -- | 6.20 | -0.2761 | -0.2761 | 0.8501 | 1.40 | 0.4762 | 1.69 | 4.10 | 129,035.10 | -15.71 | -12.95 | -19.11 | -15.90 | 67.77 | 65.69 | -32.98 | -27.84 | 2.67 | -- | 0.1424 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
Paxman AB (publ) | 238.86m | 28.64m | 1.06bn | 102.00 | 37.12 | 7.27 | 22.60 | 4.44 | 1.50 | 1.50 | 12.54 | 7.67 | 1.31 | 2.74 | 6.56 | 2,624,791.00 | 15.66 | -5.08 | 20.74 | -7.76 | 70.27 | 69.38 | 11.99 | -5.07 | 1.98 | 12.73 | 0.0838 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
BioPorto A/S | 51.65m | -76.36m | 1.21bn | 33.00 | -- | 7.54 | -- | 23.37 | -0.1397 | -0.1397 | 0.0941 | 0.244 | 0.2777 | 3.23 | 9.02 | 1,091,290.00 | -41.06 | -71.10 | -51.28 | -96.55 | 71.13 | 63.38 | -147.84 | -239.22 | 5.16 | -- | 0.0517 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
ADDvise Group AB (publ) | 1.54bn | 137.40m | 1.25bn | 637.00 | 16.41 | 2.88 | 5.24 | 0.8088 | 0.7191 | 0.7191 | 8.07 | 4.10 | 0.5142 | 7.24 | 5.04 | 2,474,039.00 | 4.58 | 3.72 | 5.63 | 4.77 | 44.82 | 48.95 | 8.91 | 5.89 | 1.36 | 3.24 | 0.6913 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
C Rad AB | 458.22m | 48.23m | 1.27bn | 89.00 | 26.95 | 4.47 | 22.04 | 2.76 | 1.43 | 1.43 | 13.57 | 8.61 | 1.20 | 4.90 | 3.05 | 5,266,839.00 | 12.69 | 5.09 | 17.96 | 7.02 | 45.14 | 43.12 | 10.61 | 4.86 | 2.43 | -- | 0.0058 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
Bactiguard Holding AB | 230.51m | -76.04m | 1.55bn | 177.00 | -- | 5.31 | -- | 6.71 | -2.17 | -2.17 | 6.58 | 9.37 | 0.3266 | 3.61 | 7.52 | 1,062,240.00 | -10.77 | -7.56 | -14.93 | -8.81 | 43.80 | 47.91 | -32.99 | -26.28 | 0.5741 | -3.93 | 0.4215 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
Nordhealth As | 469.40m | -106.06m | 1.58bn | 355.00 | -- | 3.12 | 95.75 | 3.38 | -1.40 | -1.40 | 6.16 | 11.56 | 0.4329 | -- | 6.73 | 1,221,097.00 | -9.78 | -- | -11.11 | -- | 85.82 | -- | -22.59 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
Genovis AB | 127.02m | 17.25m | 1.64bn | 37.00 | 94.88 | 7.88 | 56.31 | 12.88 | 0.2635 | 0.2635 | 1.94 | 3.17 | 0.4938 | -- | -- | 3,432,973.00 | 6.71 | 18.56 | 7.21 | 21.45 | 64.41 | 65.51 | 13.58 | 23.88 | -- | 697.00 | 0.2718 | 0.00 | 54.54 | 35.56 | 449.56 | -- | 47.59 | -- |
Stille AB | 429.68m | 47.88m | 1.90bn | 143.00 | 30.94 | 2.89 | 27.70 | 4.43 | 6.85 | 6.85 | 61.34 | 73.40 | 0.6219 | 1.97 | 8.16 | 4,053,557.00 | 6.93 | 7.03 | 8.32 | 8.19 | 47.97 | 43.93 | 11.14 | 9.85 | 1.07 | 11.55 | 0.00 | 21.98 | 19.70 | 16.78 | -2.48 | 5.34 | 23.62 | -- |
Sedana Medical AB (publ) | 168.68m | -41.47m | 2.31bn | 81.00 | -- | 2.38 | -- | 13.72 | -0.4175 | -0.4175 | 1.70 | 9.79 | 0.1609 | 1.19 | 10.82 | 2,135,139.00 | -3.95 | -5.77 | -4.17 | -6.08 | 70.32 | 64.06 | -24.59 | -36.13 | 5.66 | -- | 0.0081 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
Holder | Shares | % Held |
---|---|---|
Nordea Investment Management ABas of 31 Dec 2023 | 3.47m | 11.18% |
Fj�rde AP-fondenas of 31 Dec 2023 | 3.37m | 10.86% |
Handelsbanken Fonder ABas of 31 Dec 2023 | 1.97m | 6.33% |
AMF Fonder ABas of 31 Dec 2023 | 1.71m | 5.50% |
Lancelot Asset Management ABas of 31 Dec 2023 | 490.00k | 1.58% |
Storebrand Asset Management ASas of 30 Jun 2024 | 263.07k | 0.85% |
SEB Investment Management ABas of 13 May 2024 | 90.50k | 0.29% |
FCG Fonder ABas of 31 Dec 2023 | 78.00k | 0.25% |
Skandia Investment Management ABas of 31 May 2024 | 65.21k | 0.21% |
Deka Investment GmbHas of 31 Mar 2024 | 24.00k | 0.08% |